Testing the Combination of Afatinib and Cetuximab Compared to Afatinib Alone in Newly Diagnosed EGFR Mutation Positive, Advanced Stage Non-Small Cell Lung Cancer

February 28, 2017
S1403
Lung Cancer
Amaryllis Gil, MD
Edward Cancer Center - Naperville
Edward Cancer Center - Plainfield
Nancy Knowles Cancer Center - Elmhurst

To compare any good and bad effects of using afatinib along with cetuximab to using afatinib alone.

Sponsor: SWOG (formerly the Southwest Oncology Group)

https://clinicaltrials.gov/ct2/show/NCT02438722

  • Confirmed stage IV or recurrent non-small cell lung cancer
  • Presence of a positive EGFR
3 years
Accepting Participants
Interventional
II/III
Kathy Seymour, BSN
630-646-6075
630-646-6110
630-646-6072